Despite these limitations, this study identified older age (>65 years), MGMT non-methylation, and non-GTR as adverse prognostic factors in patients with glioblastoma who underwent standard treatment according to Stupp’s protocol. The gene discussed is MGMT; the disease is glioblastoma.